American Century Companies »

Y Mabs Therapeutics shares owned by American Century Companies

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by American Century Companies from 13F filings

Historical chart of American Century Companies investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by American Century Companies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by American Century Companies

Quarter filed Position value Share count Share price at filing
2024-03-31 $745k 46k 16.26
2023-09-30 $119k 22k 5.45
2023-06-30 $89k 13k 6.79

More positions owned by American Century Companies

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
salesforce (CRM)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)

View all positions for American Century Companies

Top funds holding Y Mabs Therapeutics

BlackRock
Paradigm Biocapital Advisors
Sofinnova Ventures
Vanguard Group
Polar Capital Holdings
Point72 Asset Management
D. E. Shaw & Co
State Street Corporation
Pictet Asset Management Holding SA
Geode Capital Management
Acadian Asset Management
Caligan Partners
Soleus Capital Management
Dimensional Fund Advisors
Goldman Sachs Group

View all funds holding Y Mabs Therapeutics